NCT06005701

Brief Summary

To predict the majority of Mallampati score for the patients in Qassim region who undergoing Laparoscopic Cholecystectomy Surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
470

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 15, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 22, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

August 28, 2023

Status Verified

August 1, 2023

Enrollment Period

12 months

First QC Date

August 15, 2023

Last Update Submit

August 24, 2023

Conditions

Mallampati ScoreDifficult IntubationPatient SatisfactionCholestasisCholecystitis

Keywords

Mallampati ScoreSurgeryAnesthesia

Outcome Measures

Primary Outcomes (1)

  • Surveillance

    predict the majority of Mallampati score for the patients in Qassim region who undergoing Laparoscopic Cholecystectomy Surgery.

    3 months

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

All patients underwent or planned for Laparoscopic Cholecystectomy

You may qualify if:

  • Age: 20 - 50 years
  • Laparoscopic Cholecystectomy Surgery
  • Body Mass Index (BMI): ≤ 35

You may not qualify if:

  • Age Less than 20 years
  • Age More than 50 years
  • Body Mass Index (BMI) \> 35

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Qassim University Medical City

Buraidah, Al-Qassim Region, 51411, Saudi Arabia

Location

MeSH Terms

Conditions

Patient SatisfactionCholestasisCholecystitis

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehaviorBile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesGallbladder Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 15, 2023

First Posted

August 22, 2023

Study Start

January 1, 2022

Primary Completion

December 30, 2022

Study Completion

September 30, 2023

Last Updated

August 28, 2023

Record last verified: 2023-08

Locations

SA(1)